Muhammad Atif1, Muhammad Azeem1, Muhammad Rehan Sarwar2, Arslan Bashir1. 1. Department of Pharmacy, The Islamia University of Bahawalpur, Punjab, Pakistan. 2. Department of Pharmacy, The Islamia University of Bahawalpur, Punjab, Pakistan. rehansarwaralvi@gmail.com.
Abstract
BACKGROUND: The massive pandemic of Zika virus (ZIKV) infection is spreading through South America, Central America, the Caribbean, and possibly the USA. It is the most recent of four surprising appearances of imperative arthropod-borne viral illnesses in the Western Hemisphere over the preceding 20 years. OBJECTIVE: The objective of this narrative review is to summarize the existing knowledge about the epidemiology, transmission, clinical manifestations, complications, replication, pathogenesis, diagnosis, and treatment and prevention of ZIKV infection. METHODS: We used electronic databases to identify relevant published data regarding ZIKV in BOOLEAN and MeSH searches. CONCLUSION: This review concludes that the ZIKV predominantly circulates in arboreal mosquitoes (e.g., Aedes africanus) and wild primates. It rarely causes severe infection in humans, even in extremely enzootic regions. Currently, we do not have any efficacious drugs against ZIKV infection. However, there are virus-specific therapeutic targets, which may lead to the development of targeted anti-ZIKV drugs.
BACKGROUND: The massive pandemic of Zika virus (ZIKV) infection is spreading through South America, Central America, the Caribbean, and possibly the USA. It is the most recent of four surprising appearances of imperative arthropod-borne viral illnesses in the Western Hemisphere over the preceding 20 years. OBJECTIVE: The objective of this narrative review is to summarize the existing knowledge about the epidemiology, transmission, clinical manifestations, complications, replication, pathogenesis, diagnosis, and treatment and prevention of ZIKV infection. METHODS: We used electronic databases to identify relevant published data regarding ZIKV in BOOLEAN and MeSH searches. CONCLUSION: This review concludes that the ZIKV predominantly circulates in arboreal mosquitoes (e.g., Aedes africanus) and wild primates. It rarely causes severe infection in humans, even in extremely enzootic regions. Currently, we do not have any efficacious drugs against ZIKV infection. However, there are virus-specific therapeutic targets, which may lead to the development of targeted anti-ZIKV drugs.
Authors: S Kutsuna; Y Kato; T Takasaki; Ml Moi; A Kotaki; H Uemura; T Matono; Y Fujiya; M Mawatari; N Takeshita; K Hayakawa; S Kanagawa; N Ohmagari Journal: Euro Surveill Date: 2014-01-30
Authors: Janneke W Duijster; Abraham Goorhuis; Perry J J van Genderen; Leo G Visser; Marion P Koopmans; Johan H Reimerink; Martin P Grobusch; Annemiek A van der Eijk; Johannes H C T van den Kerkhof; Chantal B Reusken; Susan J M Hahné Journal: Infection Date: 2016-05-21 Impact factor: 3.553
Authors: Diego Vasquez; Ana Palacio; Jose Nuñez; Wladimir Briones; John C Beier; Denisse C Pareja; Leonardo Tamariz Journal: Am J Public Health Date: 2017-05-18 Impact factor: 9.308
Authors: Laura Medeiros Andrade; Maria Dalva Baker Meio; Saint Clair Gomes; Juliana Paiva Souza; Mirza R Figueiredo; Roozemeria Pereira Costa; Patricia Brasil; Karin Nielsen-Saines; Elizabeth Brickley; Maria Elisabeth Lopes Moreira Journal: Acta Paediatr Date: 2021-05-03 Impact factor: 4.056